Antifibrotic activity of Taraxacum officinale root in carbon tetrachloride-induced liver damage in mice

Journal of Ethnopharmacology

Volumn 130, Issue 3, 2010, Pages 569-577

  Domitrović, Robert ^a   Jakovac, Hrvoje ^a   Romić, Željko ^b   Rahelić, Dario ^b   Tadić, Žarko ^a  

^a UNIVERSITY OF RIJEKA   (Croatia)

^b University of Zagreb School of Medicine   (Croatia)

Author keywords

Smooth muscle actin; Carbon tetrachloride; Dandelion (Taraxacum officinale); Glial fibrillary acidic protein; Liver fibrosis; Metallothionein

Indexed keywords

ALCOHOL; ALPHA SMOOTH MUSCLE ACTIN; CARBON TETRACHLORIDE; COLLAGEN; COPPER ZINC SUPEROXIDE DISMUTASE; GLIAL FIBRILLARY ACIDIC PROTEIN; HYDROXYPROLINE; METALLOTHIONEIN I; METALLOTHIONEIN II; OLIVE OIL; PLANT EXTRACT; TARAXACUM OFFICINALE EXTRACT; UNCLASSIFIED DRUG; WATER; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DANDELION; DRUG ACTIVITY; ENZYME ACTIVITY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIVER FIBROSIS; LIVER INJURY; LIVER PROTECTION; LIVER TOXICITY; LIVER WEIGHT; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PLANT ROOT; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; LIVER CIRRHOSIS; METABOLISM; PATHOPHYSIOLOGY; STELLATE CELL; TOXICITY; TRADITIONAL MEDICINE;

ANIMALS; CARBON TETRACHLORIDE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HEPATIC STELLATE CELLS; LIVER CIRRHOSIS; MALE; MEDICINE, TRADITIONAL; MICE; MICE, INBRED BALB C; OXIDATIVE STRESS; PLANT EXTRACTS; PLANT ROOTS; SUPEROXIDE DISMUTASE; TARAXACUM;

MUS; TARAXACUM OFFICINALE;

EID: 77954955312     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2010.05.046     Document Type: Article

References (33)

1. Bataller R., Brenner D.A. Liver fibrosis. Journal of Clinical Investigation 2005, 115:209-218.
2. Bergman A., Loxley R. Two improved and simplified method for the determination of hydroxyproline. Analytical Chemistry 1963, 35:1961-1964.
3. Benzie I.F.F., Strain J.J. The ferric reducing ability of plasma as a measure of " antioxidant power" , the FRAP assay. Analytical Biochemistry 1996, 239:70-76.
4. Blois M.S. Antioxidant determinations by the use of a stable free radical. Nature 1958, 181:1199-1200.
5. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 1976, 72:248-254.
6. Buniatian G.H. Stages of activation of hepatic stellate cells, effects of ellagic acid, an inhibiter of liver fibrosis, on their differentiation in culture. Cell Proliferation 2003, 36:307-319.
7. Burt A.D. Pathobiology of hepatic stellate cells. Journal of Gastroenterology 1999, 34:299-304.
8. Campbell J.S., Hughes S.D., Gilbertson D.G., Palmer T.E., Holdren M.S., Haran A.C., Odell M.M., Bauer R.L., Ren H.P., Haugen H.S., Yeh M.M., Fausto N. Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma. The Proceedings of the National Academy of Sciences USA 2005, 102:3389-3394.
9. Carrera G., Paternain J.L., Carrere N., Folch J., Courtade-Saïdi M., Orfila C., Vinel J.P., Alric L., Pipy B. Hepatic metallothionein in patients with chronic hepatitis C, relationship with severity of liver disease and response to treatment. American Journal of Gastroenterology 2003, 98:1142-1149.
10. Cherian M.G., Kang Y.J. Metallothionein and liver cell regeneration. Experimental Biology and Medicine (Maywood) 2006, 231:138-144.
11. Domitrović R., Jakovac H., Grebić D., Milin Č., Radošević-Stašić B. Dose- and time-dependent effects of luteolin on liver metallothioneins and metals in carbon tetrachloride-induced hepatotoxicity in mice. Biological Trace Element Research 2008, 126:176-185.
12. Domitrović R., Jakovac H., Tomac J., Šain I. Liver fibrosis in mice induced by carbon tetrachloride and its reversion by luteolin. Toxicology and Applied Pharmacology 2009, 241:311-321.
13. European Pharmacopoeia, Supplement 6.6, 2009. Monographs, Dandelion root, pp. 5232-5233.
14. Gurib-Fakim A. Medicinal plants: traditions of yesterday and drugs of tomorrow. Molecular Aspects of Medicine 2006, 27:1-93.
15. Guyot C., Lepreux S., Combe C., Doudnikoff E., Bioulac-Sage P., Balabaud C., Desmoulière A. Hepatic fibrosis and cirrhosis, the (myo)fibroblastic cell subpopulations involved. The International Journal of Biochemistry and Cell Biology 2006, 38:135-151.
16. Hegi G. Illustrierte Flora von Mitteleuropa. Compositae II 1987, vol. 4. Paul Parey, Berlin, Hamburg. 2nd ed.
17. Jiang Y., Kang Y.J. Metallothionein gene therapy for chemical-induced liver fibrosis in mice. Molecular Therapy 2004, 10:1130-1139.
18. Jin Y.L., Enzan H., Kuroda N., Hayashi Y., Nakayama H., Zhang Y.H., Toi M., Miyazaki E., Hiroi M., Guo L.M., Saibara T. Tissue remodeling following submassive hemorrhagic necrosis in rat livers induced by an intraperitoneal injection of dimethylnitrosamine. Virchows Archiv 2002, 442:39-47.
19. Kinnman N., Hultcrantz R., Barbu V., Rey C., Wendum D., Poupon R., Housset C. PDGF-mediated chemoattraction of hepatic stellate cells by bile duct segments in cholestatic liver injury. Laboratory Investigation 2000, 80:697-707.
20. Levadoux-Martin M., Hesketh J.E., Beattie J.H., Wallace H.M. Influence of metallothionein-1 localization on its function. Biochemical Journal 2001, 355:473-479.
21. Marra F., Romanelli R.G., Giannini C., Failli P., Pastacaldi S., Arrighi M.C., Pinzani M., Laffi G., Montalto P., Gentilini P. Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. Hepatology 1999, 29:140-148.
22. Moreira R.K. Hepatic stellate cells and liver fibrosis. Archives of Pathology and Laboratory Medicine 2007, 131:1728-1734.
23. Natarajan S.K., Thomas S., Ramamoorthy P., Basivireddy J., Pulimood A.B., Ramachandran A., Balasubramanian K.A. Oxidative stress in the development of liver cirrhosis, a comparison of two different experimental models. Journal of Gastroenterology and Hepatology 2006, 21:947-957.
24. Neubauer K., Knittel T., Aurisch S., Fellmer P., Ramadori G. Glial fibrillary acidic protein - a cell type specific marker for Ito cells in vivo and in vitro. Journal of Hepatology 1996, 24:719-730.
25. Parola M., Robino G. Oxidative stress-related molecules and liver fibrosis. Journal of Hepatology 2001, 35:297-306.
26. Poli G. Pathogenesis of liver fibrosis, role of oxidative stress. Molecular Aspects of Medicine 2000, 21:49-98.
27. Rácz-Kotilla E., Rácz G., Solomon A. The action of Taraxacum officinale extracts on the body weight and diuresis of laboratory animals. Planta Medica 1974, 26:212-217.
28. Sato M., Bremner I. Oxygen free radicals and metallothionein. Free Radical Biology and Medicine 1993, 14:325-337.
29. Schütz K., Kammerer D.R., Carle R., Schieber A. Characterization of phenolic acids and flavonoids in dandelion (Taraxacum officinale WEB. ex WIGG.) root and herb by high-performance liquid chromatography/electrospray ionization mass spectrometry. Rapid Communications in Mass Spectrometry 2005, 19:179-186.
30. Schütz K., Carle R., Schieber A. Taraxacum - a review on its phytochemical and pharmacological profile. Journal of Ethnopharmacology 2006, 107:313-323.
31. Shi H., Dong L., Bai Y., Zhao J., Zhang Y., Zhang L. Chlorogenic acid against carbon tetrachloride-induced liver fibrosis in rats. European Journal of Pharmacology 2009, 623:119-124.
32. Sugatani J., Wada T., Osabe M., Yamakawa K., Yoshinari K., Miwa M. Dietary inulin alleviates hepatic steatosis and xenobiotics-induced liver injury in rats fed a high-fat and high-sucrose diet, association with the suppression of hepatic cytochrome P450 and hepatocyte nuclear factor 4-alpha expression. Drug Metabolism and Disposition 2006, 34:1677-1687.
33. Swain T., Hills W.E. The phenolic constituents of Prunus domestica. Journal of the Science of Food and Agriculture 1959, 10:63-68.